Carpenter Technology Corporation (CRS)
Is Carpenter Technology (CRS) Stock Outpacing Its Basic Materials Peers This Year?
Here is how Carpenter Technology (CRS) and Element Solutions (ESI) have performed compared to their sector so far this year.
Carpenter Technology (CRS) Crossed Above the 20-Day Moving Average: What That Means for Investors
After reaching an important support level, Carpenter Technology (CRS) could be a good stock pick from a technical perspective. CRS surpassed resistance at the 20-day moving average, suggesting a short-term bullish trend.
Can CRS Achieve Its Upbeat FY26 Operating Income Guidance?
Carpenter Technology lifts its FY26 operating income outlook after a record third quarter, driven by aerospace and defense demand, pricing, and volume gains.
Carpenter (CRS) Moves to Buy: Rationale Behind the Upgrade
Carpenter (CRS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Here's Why Carpenter Technology (CRS) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Will Carpenter (CRS) Beat Estimates Again in Its Next Earnings Report?
Carpenter (CRS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
3 Reasons Why Growth Investors Shouldn't Overlook Carpenter (CRS)
Carpenter (CRS) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Are You Looking for a Top Momentum Pick? Why Carpenter Technology (CRS) is a Great Choice
Does Carpenter Technology (CRS) have what it takes to be a top stock pick for momentum investors? Let's find out.
Carpenter Technology (CRS) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Organon Wins FDA Nod to Expand TOFIDENCE Use in Severe CRS & COVID-19
OGN's TOFIDENCE gains FDA approval for life-threatening CRS and certain hospitalized COVID-19 patients, broadening its critical-care role.
Carpenter Technology Corporation (CRS) Hits Fresh High: Is There Still Room to Run?
Carpenter (CRS) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Why Carpenter Technology (CRS) is a Top Growth Stock for the Long-Term
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
